About Grass Technologies
Grass Technologies is a company based in United States founded in 2006 was acquired by Natus in January 2013. Grass Technologies operates in a competitive market with competitors including Sunbird Bio, BrainSpec, Quadrant Biosciences, Danyang Huichuang Medical Equipment and SyntheticMR, among others.
- Headquarter West, United States
- SectorsHealthcare
- Website grasstechnologies.com
- Social LinkedIn Facebook
- Acquired by Natus (Jan 2013)
- Investors
- Acquired byNatus
(Jan 2013)
Investors in Grass Technologies
Grass Technologies has secured backing from 1 investor. Prominent investors backing the company include Natus Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical devices for screening, diagnosing, and treating disorders are provided. | 1935 | natus.com | San Carlos, United States |
Investor details for Grass Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Grass Technologies
2 dated milestones of Grass Technologies across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Grass Technologies is founded.
- Exit Acquired by Natus.
Competitors of Grass Technologies
Grass Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sunbird Bio, BrainSpec, Quadrant Biosciences, Danyang Huichuang Medical Equipment and SyntheticMR, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sunbirdbio.com | 2020 | Singapore | $14M | – | Diagnostic technologies for infectious, cancer, and neurological diseases are developed. | |
| brainspecmed.com | 2015 | Boston, United States | $5.59M | – | Web-based MRS platform for brain metabolite analysis is utilized. | |
| quadrantbiosciences.com | 2015 | Syracuse, United States | – | – | Technologies for the evaluation of brain health and autism spectrum disorders | |
| hcmedx.cn | 2016 | Haidian, China | $16.63M | – | Provider of infrared spectroscopy brain function imaging solutions | |
| syntheticmr.com | 2007 | Linkoping, Sweden | – | – | Software solutions for Magnetic Resonance Imaging are provided. | |
| courtagen.com | 2009 | Woburn, United States | $41.31M | 128 | Provides solutions for neurological and metabolic disorders. | |
| mursla.com | 2017 | London, United Kingdom | $547,194 | 9 | Diagnostic devices for cancer detection are developed using nanostructures. | |
| imeka.ca | 2011 | Sherbrooke, Canada | – | 19 | MRI-based diagnostic software using AI and diffusion imaging is developed. |
Detailed competitors of Grass Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Grass Technologies
10 companies that operate in the same segment as Grass Technologies (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Grass Technologies
Grass Technologies was founded in 2006.
Grass Technologies is headquartered in United States.
Grass Technologies was founded in 2006 as a subsidiary of Astro-Med and later acquired by Natus Medical Incorporated in 2013. Operations focus on the production and distribution of neurophysiological instruments within the medical devices sector, including amplifiers, EEG systems, polysomnography products, transducers, electrodes, sensors, and related software for data acquisition and analysis. These items support research and clinical applications, primarily in the western United States.
Grass Technologies's top competitors include Sunbird Bio, Mursla and SyntheticMR.
Grass Technologies has 1 investor. Key investors include Natus Medical.
Yes. Grass Technologies was acquired by Natus in January 2013.